KalVista Pharmaceuticals, Inc.
KALVDelisted Jun 11, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001348911
KalVista Pharmaceuticals, Inc. was delisted on Jun 11, 2026; its insiders filed their last Form 4 on Jun 11, 2026; 184 institutions reported holding it in 13F filings for Q1 2026, worth $1.39B in total; no superinvestor held it.
Q2 2022 vs. Q1 2022
How the institutions holding KalVista Pharmaceuticals, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 89 | 2 | 91 | +4 |
| Shares | 24.3M | 34.0K | 24.3M | −42.6K (−0.2%) |
| Value | $363.9M | $501.0K | $238.7M | −$124.7M (−34.3%) |
2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (17)
Institutions that held KalVista Pharmaceuticals, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| OrbiMed Advisors LLC | 185,400 | $1.82M | 0.04% |
| HRT Financial LP | 68,778 | $676.0K | 0.01% |
| D. E. Shaw & Co., Inc. | 54,976 | $541.0K | 0.00% |
| Cubist Systematic Strategies, LLC | 50,514 | $497.0K | 0.00% |
| Trexquant Investment LP | 39,048 | $384.0K | 0.02% |
| Two Sigma Investments, LP | 37,453 | $369.0K | 0.00% |
| Jump Financial, LLC | 23,100 | $227.0K | 0.01% |
| Engineers Gate Manager LP | 16,721 | $165.0K | 0.01% |
| SG Americas Securities, LLC | 16,691 | $164.0K | 0.00% |
| Norges Bank | 14,900 | $146.6K | 0.00% |
| PDT Partners, LLC | 14,113 | $139.0K | 0.01% |
| Dynamic Technology Lab Private Ltd | 13,969 | $137.0K | 0.02% |
| Manufacturers Life Insurance Company, The | 10,514 | $103.5K | 0.00% |
| Quantbot Technologies LP | 3,500 | $34.0K | 0.00% |
| Point72 Hong Kong Ltd | 2,646 | $26.0K | 0.00% |
| TCI Wealth Advisors, Inc. | 360 | $4.00K | 0.00% |
| Credit Suisse AG | 24 | $0 | 0.00% |
Sold out (13)
Institutions that held KalVista Pharmaceuticals, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Ra Capital Management, L.P. | 1,930,322 | $28.5M |
| Franklin Resources Inc | 1,239,731 | $18.3M |
| Deerfield Management Company, L.P. (Series C) | 830,472 | $12.2M |
| Monashee Investment Management LLC | 264,111 | $3.89M |
| Rafferty Asset Management, LLC | 47,549 | $701.0K |
| Ikarian Capital, LLC | 39,730 | $586.0K |
| Susquehanna International Group, LLP | 12,558 | $185.0K |
| Prudential Financial Inc | 11,835 | $174.0K |
| Virtus ETF Advisers LLC | 11,784 | $174.0K |
| Allspring Global Investments Holdings, LLC | 1,600 | $23.0K |
| Aquatic Capital Management LLC | 200 | $3.00K |
| Lindbrook Capital, LLC | 112 | $2.00K |
| CWM, LLC | 11 | $0 |
Not filed for Q2 2022 yet (2)
Institutions that held KalVista Pharmaceuticals, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Teachers Retirement System of the State of Kentucky | 30,335 | $447.0K |
| Amalgamated Financial Corp. | 3,652 | $54.0K |